Background: Parents of children with cancer experience significant psychological distress that is associated with poorer health outcomes. A recent review of caregiver interventions illustrated none targeting Latino parents of children with cancer and a significant need for culturally congruent intervention approaches. Aims: Following our first paper in this issue describing the development of a community co-developed intervention to address psychosocial outcomes in Spanish-speaking Latino families impacted by childhood cancer, this second paper describes the formative evaluation and exploratory analysis of preliminary efficacy in a single-arm pre–post trial. Methods: A total of 32 Spanish-speaking Latino parents/caregivers of children with cancer received the 12-session intervention targeting health literacy, culturally congruent care, and caregiver well-being. Quantitative measures of health literacy and emotional well-being were collected at baseline, post-intervention, and 3 months post-intervention and mixed methods formative evaluation data were collected immediately post-intervention. Results: Mixed methods formative evaluation showed that the intervention was useful, helpful, and relevant. Exploratory preliminary efficacy data using a non-parametric Friedman test showed that health literacy doubled from pre- (33%) to post-intervention (67%) and was sustained at 3 months (X2(2) = 12.52, p = 0.002; Cohen’s d = 0.65). Repeated measures ANOVA showed that emotional distress decreased significantly from baseline to immediately post-intervention with sustained treatment effects at 3 months post-intervention (F(2,62) = 4.37, p = 0.046; Cohen’s d = 0.42). Satisfaction scores were well above treatment acceptability (M = 39.13, SD = 2.80). Conclusions: Implementation of a community co-developed intervention with the goal of achieving cultural congruency was feasible, likeable, and relevant for Spanish-speaking Latino parents and caregivers of children undergoing treatment for cancer. Moreover, the exploratory analysis showed the intervention was associated with improvements in health literacy and emotional well-being and high levels of treatment satisfaction.
Background: Cancer health disparities among Latinos in the United States are pervasive and manifest in higher morbidity and mortality among pediatric cancer patients and their parents/caregivers. There is a need to engage in culturally congruent approaches to develop interventions that effectively mitigate cancer health disparities among Latino caregivers. Aims: The purpose of this manuscript is to present the methodological process of adopting a community-based participatory research (CBPR) approach to develop a culturally congruent intervention to address psychosocial cancer health disparities in Spanish-speaking Latino families impacted by childhood cancer. Materials and Methods: We established two partnerships with Spanish-speaking parents of children previously treated for cancer and whose children were currently undergoing cancer treatment to collaboratively identify psychosocial intervention targets. A total of 22 meetings were held with community collaborators (n = 13) that followed CBPR principles. All meetings were audio recorded, transcribed, and coded using an inductive approach. Results: The intervention framework identified three psychosocial outcomes: caregiver health literacy, culturally congruent care, and emotional well-being. A 12-session intervention addressing the three outcomes was developed integrating cultural values and bilingual and bicultural community and healthcare providers. Conclusions: A CBPR approach was adopted to address disparities in quality of life in Spanish-speaking caregivers of children with cancer, which resulted in a multicomponent intervention that addresses the informational, practical, and psychosocial needs of Latino caregivers. The intervention can help mitigate disparities in well-being for Latino families impacted by childhood cancer by incorporating culturally relevant strategies to optimize health.
Background: Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited. We sought to understand the communication experiences of Spanish‐speaking caregivers during a new childhood cancer diagnosis and elicit recommendations for improving family‐centered diagnostic communication. Methods: We conducted semi‐structured qualitative interviews in Spanish with adult Spanish‐speaking caregivers present during the initial oncology diagnosis conversation for a child diagnosed within the prior 10 years. Participants were recruited from two US pediatric centers using purposeful sampling. Bilingual interviewers conducted interviews from July 2024 to May 2025. Transcripts were analyzed using inductive qualitative content analysis by two independent bilingual coders, with iterative codebook development and constant comparison until thematic saturation. Results: Eleven mothers participated, all born outside the US; most children had hematologic malignancies. Five themes were identified as follows: (1) interpreter access and quality impacted understanding; (2) strong emotional responses to diagnosis, sometimes framed by cultural beliefs; (3) difficulty voicing concerns due to language differences; (4) experiencing connection when clinicians took time to communicate the diagnosis; and (5) recommendations, including more bilingual clinicians, in‐person professional interpreters, plain‐language explanations, and cultural humility training. Conclusions: Meaningful communication with Spanish‐speaking families at diagnosis requires systems‐level investment in qualified interpreters and bilingual clinicians, clinician behaviors that invite questions and validate emotion, and culturally responsive care.
2 October 2026 in Pediatric, Adolescent & Young Adult Cancer
Introduction: Electroacupuncture (EA) shows promise for managing neuropsychiatric symptoms, yet its role in adolescents and young adults (AYAs) living with cancer remains unclear. This is a randomized, controlled, patient‐blinded and assessor‐blinded pilot trial comparing two EA regimens to evaluate the improvement of neuropsychiatric symptoms and associated biomarkers in AYA cancer survivors. Methods: AYA cancer survivors aged 16–39 years who self‐reported cognitive impairment, fatigue, insomnia, or psychological distress were randomized (1:1) to receive 10 weekly EA sessions targeting either neuropsychiatric‐specific acupoints (nEA) or non‐neuropsychiatric‐specific acupoints (active control; cEA). Blood collection, neurocognitive testing, and patient‐reported outcomes were obtained at four timepoints. Results: Thirty‐four AYAs participated (mean ± standard deviation age, 20.9 ± 3.5 years). Of these, 82% reported two or more neuropsychiatric symptoms at baseline. Completion of all EA sessions was comparable between study arms (nEA, 64.7%; cEA, 70.6%). Symptom improvement increased over time in both arms, with approximately one half reporting symptom improvement mid‐treatment (nEA, 53.8%; cEA, 60.0%) and ≥80% reporting improvement at 4 weeks posttreatment (nEA, 80.0%; cEA, 92.3%). At the end of treatment, greater improvement in attention (Cohen d = 1.480; p < .05) in the nEA arm and response speed (Cohen d = −1.091; p < .05) in the cEA arm were observed. Brain‐derived neurotrophic factor levels were higher in the cEA arm (d = −1.073; p < .05), whereas interleukin‐10 (Cohen d = 1.378; p < .05) and RANTES (Cohen d = 1.058; p < .05) levels were greater in the nEA arm. All adverse events were grade ≤2. Conclusion: AYAs across both EA regimens demonstrated meaningful improvements in neuropsychiatric symptoms, accompanied by corresponding biomarker changes. However, maximal benefit occurred among the participants who completed all scheduled sessions, underscoring the importance of strategies to optimize EA session adherence ( ClinicalTrials.gov identifier NCT05283577).